# Effects on NF-κB Activity: High Dose Simvastatin Versus Combination Therapy With Ezetimibe

> **NCT01424891** · NA · COMPLETED · sponsor: **Heidelberg University** · enrollment: 31 (actual)

## Conditions studied

- Type 2 Diabetes
- Inflammation

## Interventions

- **DRUG:** Simvastatin 80 mg
- **DRUG:** Sim10/Eze10
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01424891
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2006-07
- **Final completion:** 2011-08
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2011-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01424891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01424891, "Effects on NF-κB Activity: High Dose Simvastatin Versus Combination Therapy With Ezetimibe". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01424891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*